These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23627619)

  • 1. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.
    De Simone G; Alterio V; Supuran CT
    Expert Opin Drug Discov; 2013 Jul; 8(7):793-810. PubMed ID: 23627619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors drug design.
    McKenna R; Supuran CT
    Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How many carbonic anhydrase inhibition mechanisms exist?
    Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(3):345-60. PubMed ID: 26619898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.
    Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Supuran CT
    Chem Commun (Camb); 2012 Feb; 48(13):1868-70. PubMed ID: 22218610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
    Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
    J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors.
    Winum JY; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):321-4. PubMed ID: 24939097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based drug discovery of carbonic anhydrase inhibitors.
    Supuran CT
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):759-72. PubMed ID: 22468747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery.
    Nocentini A; Supuran CT
    Expert Opin Drug Discov; 2019 Nov; 14(11):1175-1197. PubMed ID: 31436118
    [No Abstract]   [Full Text] [Related]  

  • 10. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.
    Nocentini A; Angeli A; Carta F; Winum JY; Zalubovskis R; Carradori S; Capasso C; Donald WA; Supuran CT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):561-580. PubMed ID: 33615947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site.
    Tanpure RP; Ren B; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2015 Feb; 58(3):1494-501. PubMed ID: 25581127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
    Carta F; Temperini C; Innocenti A; Scozzafava A; Kaila K; Supuran CT
    J Med Chem; 2010 Aug; 53(15):5511-22. PubMed ID: 20590092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors.
    Supuran CT
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3467-74. PubMed ID: 20529676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
    Aggarwal M; McKenna R
    Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of carbonic anhydrases.
    Supuran CT
    Biochem J; 2016 Jul; 473(14):2023-32. PubMed ID: 27407171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors.
    Maresca A; Temperini C; Vu H; Pham NB; Poulsen SA; Scozzafava A; Quinn RJ; Supuran CT
    J Am Chem Soc; 2009 Mar; 131(8):3057-62. PubMed ID: 19206230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zinc coordination pattern in the η-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families.
    De Simone G; Di Fiore A; Capasso C; Supuran CT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1385-9. PubMed ID: 25765908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of glycosidic carbonic anhydrase inhibitors.
    Winum JY; Poulsen SA; Supuran CT
    Med Res Rev; 2009 May; 29(3):419-35. PubMed ID: 19058143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.